肺性无心病中的结节-支气管切除模式:多中心回顾性研究中的免疫状态和治疗结果
Airi Hasegawa1, Kazuya Tone1, Yuri Baba2
1Department of Respiratory Medicine, The Jikei University School of Medicine Kashiwa Hospital, 163-1 Kashiwashita, Kashiwa, Chiba, 277-8567, Japan.
Respiratory medicine
|December 26, 2024
概括
肺性心脏病,一种罕见的感染,显示出明显的CT模式. 结节-支气管切除 (NB) 模式在免疫能力强的患者中很常见,并且与这种诺卡迪亚感染的更好的结果有关.
科学领域:
- 医学微生物学 医学微生物学
- 传染性疾病 传染性疾病
- 放射学 放射学是一门学科.
背景情况:
- 肺性心脏病是一种罕见的机会性感染,影响免疫能力和免疫功能低下的个体.
- 诺卡迪亚物种的隔离率不断增加,突出显示了其日益重要的临床意义.
- 这项研究解决了更好地识别和理解这种疾病的需要.
研究的目的:
- 要总结计算机断层扫描 (CT) 在肺非心脏病中的发现.
- 为了评估肺无心病患者的治疗结果.
- 为了提高肺无心病的识别.
主要方法:
- 在三家医院10年间对12例肺非心脏病例进行了回顾性分析.
- 通过涂抹显微镜识别病原体,并从呼吸道样本中分离.
- 排除了两个诊断不清楚的病例.
主要成果:
- 结节-支气管切除 (NB) CT 模式经常被观察到,特别是在免疫能力强的患者中.
- 与非NB模式相比,NB模式与明显更好的治疗结果相关 (p=0.0476).
- 所有的诺卡迪亚隔离物对三甲/硫甲醇敏感;8/10患者康复,而2人死亡.
结论:
- 肺性无心病表现出三个主要的CT模式,NB模式是最常见的,并且与有利的结果相关,特别是在免疫能力强的个体中.
- 诺卡迪亚物种可以与支气管切除症共存或独立引起支气管切除症.
- 在CT扫描上的NB模式证明了Nocardia感染作为差异诊断的考虑,类似于非结核性真菌菌病.
相关概念视频
01:28Pneumonia IV: Management
298
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
298
01:30Pneumonia III: Complications and Assessment
156
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
156
01:28Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
01:31Pulmonary Tuberculosis III
303
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
303
01:28Pulmonary Tuberculosis II
211
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
01:26COPD: Management Using Bronchodilators and Corticosteroids
177
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
177